Sponsor
Sponsor
PLORVO
Find Out More
GLP-1 Receptor Agonists: Mechanism, Evidence and Trial Representation – 1 CME Point
Speaker
Mr. Yousaf Ahmad
Pharmaceutical Expert
Yousaf Ahmad is a highly versatile senior executive healthcare professional known for his board-level leadership and transformational impact across large, complex healthcare organizations. With a proven track record in both NHS and corporate settings, he brings together expertise in clinical care, governance, and international pharmacy to design and deliver innovative strategies that improve efficiency, productivity, and patient outcomes. Yousaf’s strengths, as recognized by Strengthscope, include collaboration, compassion, creativity, developing others, empathy, self-improvement, and strategic-mindedness. Currently, Yousaf serves in multiple high-profile roles, including Non-executive Director, Expert Advisory Board Member, Digital Healthcare Expert, Global Pharmacy Ambassador, School Governor, and University Educator. He is especially valued for his deep knowledge in pharmaceutical practice, digital health, educational models, and for his insight into board and corporate governance at the highest level.
If you register now, then you can choose to watch it live or later. The webinar will be available later, but without any CME points.
>LIVE: 12 September 2026, Saturday 10:00 am (UK time zone)
Agenda
- 40 minutes presentation and then 20 minutes Q&A with the host Nathan Nagel
- Incretin physiology and GLP-1 mechanism of action
- Appetite regulation and central pathway
- Overview of major GLP-1 clinical trials
- Cardiovascular outcome data and implications
- Representation of South Asian, Arab and Black populations in studies
- Evidence gaps and interpretation for real-world care
- Comparing GLP-1 agents by efficacy, dosing and safety